Dr Chandradhish Ghosh


Chandradhish Ghosh has been working at the interface of chemistry, nanotechnology and infectious diseases throughout his research career. During his PhD (at JNCASR, India), he introduced a new class of membrane active small molecules that were effective against various pathogens. Before joining IMIB/HIRI, he worked at the Max Planck Institute of Colloids and Interfaces (Potsdam) towards developing glyconanomaterials and nanobody-drug conjugates as anti-infectives and immunotherapeutics. At the IMIB/HIRI, he plans to advance antisense oligomers into viable clinical candidates.